New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’ – STAT
STAT |
New CAR–T drug for leukemia, while effective, is 'going to cost a fortune'
STAT The treatment, CTL019, belongs to a new class of medications called CAR–T cell therapies, which involve harvesting patients' immune cells and genetically altering them to kill cancer. It's been tested in patients whose leukemia has relapsed in spite of … |
